Merck KGaA (MilliporeSigma)

What they make

3 inputs Merck KGaA (MilliporeSigma) supplies

Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.

Where they make it

3 facilities

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

• Did you know2023

  Merck KGaA (Darmstadt Germany; family-owned since 1668) is the only company in the world that simultaneously manufactures single-use bioreactor bags (Mobius, for biologics drug manufacturing), semiconductor photoresists (MEEF 5000-series KrF and ArF photoresists, for chip manufacturing), and liquid crystals (for Samsung and LG OLED and LCD display panels). The same 350-year-old German chemical company's operations in Darmstadt serve: biopharma manufacturers (SU bags, filtration, chromatography), semiconductor fabs (photoresists, CMP slurries, etch materials), and consumer electronics supply chains (liquid crystals in every flat-panel display). A disruption at the Darmstadt campus — fire, flood, regulatory action, or geopolitical event — would simultaneously affect drug manufacturing, chip fabrication, and display supply chains. No other company in the world spans all three of these critical-materials categories from a single campus.

  Merck KGaA ↗

• Concentration2023

  Merck KGaA (Darmstadt; family-controlled since 1668 via E. Merck OHG holding company; Merck family retains ~70% of voting shares) is the world's oldest operating pharmaceutical and chemical company — founded as an apothecary shop in Darmstadt in 1668 — and is simultaneously in 2024 a major Protein A resin manufacturer (ProSep, Eshmuno), the world's #3 photoresist producer (Lithomax, Merck semiconductor materials), the world's #1 liquid crystal materials producer (LC for LCD displays), and a producer of specialty pigments, solvents, and research chemicals. Merck KGaA's Molsheim, Alsace France facility that manufactures Eshmuno A Protein A resin is in the Alsace biopharmaceutical cluster — 50 km from Strasbourg, 80 km from Basel Switzerland (home to Roche and Novartis, the world's #1 and #2 biopharmaceutical companies by revenue). Merck KGaA's family ownership structure means it cannot be acquired without Merck family consent — a structural feature that makes its Protein A resin supply chain position stable in a way that publicly-traded competitors (Cytiva/Danaher, Repligen, Purolite/Ecolab) are not. A hostile buyer cannot acquire Merck KGaA's Protein A resin capacity.

  Merck KGaA ↗

• Incident2010

  In October 2010, Merck KGaA completed its $7.2 billion acquisition of Millipore Corporation (Billerica, MA) — then the world's largest laboratory filtration and bioprocessing consumables company, with ~$1.7B annual revenue and approximately 6,000 employees across 30 countries. The acquisition gave Merck KGaA the Durapore sterilizing membrane platform, the Millipak and Opticap filter device platforms, and the Sigma-Aldrich-competitor laboratory chemicals business (which was later separated into the Sigma-Aldrich merger in 2015 for $17B — meaning Merck spent $7.2B on Millipore in 2010, then integrated Millipore's competitor Sigma-Aldrich for $17B in 2015, creating MilliporeSigma, the combined entity that now dominates both pharmaceutical filtration and laboratory research chemicals). The 2010 Millipore acquisition transformed Merck KGaA from a primarily pharmaceutical and specialty chemical company into the world's largest pharmaceutical filtration supplier at a moment — just after H1N1 influenza pandemic — when biopharmaceutical manufacturing capacity was being rapidly expanded globally. The timing of Merck's Millipore acquisition and subsequent Sigma-Aldrich consolidation established the MilliporeSigma platform's dominant position in pharmaceutical manufacturing consumables before the COVID vaccine manufacturing surge that would, a decade later, expose the concentration risks the acquisitions created.

  Merck KGaA ↗